Global Cell-based Assay Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Cell-based Assay Market is expected to grow from USD 12,136.68 Million in 2018 to USD 19,236.68 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.80%.
The positioning of the Global Cell-based Assay Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell-based Assay Market including are Becton, Dickinson and Company, Danaher Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific Inc., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Cisbio, Lonza Group Ltd., Perkinelmer, Inc., and Promega Corporation.
On the basis of Offerings, the Global Cell-based Assay Market is studied across Consumables, Instruments, and Services.
On the basis of Application, the Global Cell-based Assay Market is studied across Basic Research and Drug Discovery.
On the basis of End User, the Global Cell-based Assay Market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cell-based Assay Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cell-based Assay Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cell-based Assay Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cell-based Assay Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cell-based Assay Market
The report answers questions such as:
1. What is the market size of Cell-based Assay market in the Global?
2. What are the factors that affect the growth in the Global Cell-based Assay Market over the forecast period?
3. What is the competitive position in the Global Cell-based Assay Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cell-based Assay Market?
5. What are the opportunities in the Global Cell-based Assay Market?
6. What are the modes of entering the Global Cell-based Assay Market?
The positioning of the Global Cell-based Assay Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell-based Assay Market including are Becton, Dickinson and Company, Danaher Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific Inc., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Cisbio, Lonza Group Ltd., Perkinelmer, Inc., and Promega Corporation.
On the basis of Offerings, the Global Cell-based Assay Market is studied across Consumables, Instruments, and Services.
On the basis of Application, the Global Cell-based Assay Market is studied across Basic Research and Drug Discovery.
On the basis of End User, the Global Cell-based Assay Market is studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cell-based Assay Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cell-based Assay Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cell-based Assay Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cell-based Assay Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cell-based Assay Market
The report answers questions such as:
1. What is the market size of Cell-based Assay market in the Global?
2. What are the factors that affect the growth in the Global Cell-based Assay Market over the forecast period?
3. What is the competitive position in the Global Cell-based Assay Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cell-based Assay Market?
5. What are the opportunities in the Global Cell-based Assay Market?
6. What are the modes of entering the Global Cell-based Assay Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Cell-based Assay Market
3.2. Opportunities in the Cell-based Assay Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
4.2.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
4.2.1.3. Rising worldwide demand for novel drugs and treatments
4.2.2. Restraints
4.2.2.1. Limited skilled professionals
4.2.3. Opportunities
4.2.3.1. Potential in emerging economies
4.2.3.2. Rising use of cell-based assays in various ultra-high throughput screening
4.2.3.3. Growing number of in-vitro drug studies based on cell-based assays
4.2.4. Challenges
4.2.4.1. Unfavourable regulatory framework
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL CELL-BASED ASSAY MARKET, BY OFFERINGS
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Consumables
5.3.1. Assay Kits
5.3.2. Cell Lines
5.3.3. Microplates
5.3.4. Probes & Labels
5.3.5. Reagents
5.4. Instruments
5.5. Services
6. GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Basic Research
6.4. Drug Discovery
6.4.1. Pharmacodynamic Studies
6.4.2. Pharmacokinetic Studies
6.4.3. Toxicity Studies
7. GLOBAL CELL-BASED ASSAY MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Academic & Government Institutes
7.4. Contract Research Organizations
7.5. Pharmaceutical & Biotechnology Companies
8. GLOBAL CELL-BASED ASSAY MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Cell-based Assay Market
9.2. Market Vendor Ranking Analysis for Global Cell-based Assay Market
9.3. Competitive News Feed Analysis for Global Cell-based Assay Market
10. COMPANY USABILITY PROFILES
10.1. Becton, Dickinson and Company
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Danaher Corporation
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. GE Healthcare
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Merck KGaA
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Thermo Fisher Scientific Inc.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Cell Biolabs, Inc.
10.7. Cell Signaling Technology, Inc.
10.8. Charles River Laboratories, Inc.
10.9. Cisbio
10.10. Lonza Group Ltd.
10.11. Perkinelmer, Inc.
10.12. Promega Corporation
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Cell-based Assay Market
3.2. Opportunities in the Cell-based Assay Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
4.2.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
4.2.1.3. Rising worldwide demand for novel drugs and treatments
4.2.2. Restraints
4.2.2.1. Limited skilled professionals
4.2.3. Opportunities
4.2.3.1. Potential in emerging economies
4.2.3.2. Rising use of cell-based assays in various ultra-high throughput screening
4.2.3.3. Growing number of in-vitro drug studies based on cell-based assays
4.2.4. Challenges
4.2.4.1. Unfavourable regulatory framework
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL CELL-BASED ASSAY MARKET, BY OFFERINGS
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Consumables
5.3.1. Assay Kits
5.3.2. Cell Lines
5.3.3. Microplates
5.3.4. Probes & Labels
5.3.5. Reagents
5.4. Instruments
5.5. Services
6. GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Basic Research
6.4. Drug Discovery
6.4.1. Pharmacodynamic Studies
6.4.2. Pharmacokinetic Studies
6.4.3. Toxicity Studies
7. GLOBAL CELL-BASED ASSAY MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Academic & Government Institutes
7.4. Contract Research Organizations
7.5. Pharmaceutical & Biotechnology Companies
8. GLOBAL CELL-BASED ASSAY MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Cell-based Assay Market
9.2. Market Vendor Ranking Analysis for Global Cell-based Assay Market
9.3. Competitive News Feed Analysis for Global Cell-based Assay Market
10. COMPANY USABILITY PROFILES
10.1. Becton, Dickinson and Company
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Danaher Corporation
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. GE Healthcare
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Merck KGaA
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Thermo Fisher Scientific Inc.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Cell Biolabs, Inc.
10.7. Cell Signaling Technology, Inc.
10.8. Charles River Laboratories, Inc.
10.9. Cisbio
10.10. Lonza Group Ltd.
10.11. Perkinelmer, Inc.
10.12. Promega Corporation
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
